Ikena Oncology announced its financial results for the quarter ended September 30, 2023 and shared initial data from the ongoing Phase I clinical trial of IK-930.
AI Assistant
IKENA ONCOLOGY INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.